Second Year MDUFMA Stats Show Catch-Up Required To Achieve Cycle Goals
This article was originally published in The Gray Sheet
Executive Summary
FDA forecasts that decision goals under the Medical Device User Fee & Modernization Act will be easier to meet than cycle goals, based on a comparison of fiscal 2003 and 2004 performance data with FY 2005 statutory benchmarks
You may also be interested in...
PMA Review Costs Pooled In Unit-Cost Analysis; CDRH To Monitor Modules
FDA's cost study of its device review resources likely will consolidate labor data for traditional, modular, expedited and panel-track PMAs into one cohort, rather than track each application type separately
PMA Review Costs Pooled In Unit-Cost Analysis; CDRH To Monitor Modules
FDA's cost study of its device review resources likely will consolidate labor data for traditional, modular, expedited and panel-track PMAs into one cohort, rather than track each application type separately
Electronic Device Reviews, Staff Training On ODE’s To-Do List In FY 2005
CDRH's Office of Device Evaluation Director Donna-Bea Tillman, PhD, plans to initiate a dialogue with industry to gauge stakeholder interest in electronic review of premarket submissions